Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTE6YDG)

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

1 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
TG003	DMP4HR2	Discovery agent	N.A.	Patented	[1]
------------------------------------------------------------------------------------

4 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
KH-CB19	DMSOB3U	Discovery agent	N.A.	Investigative	[2]
leucettine L41	DMBYND6	Discovery agent	N.A.	Investigative	[3]
ML315	DMNOREK	Discovery agent	N.A.	Investigative	[4]
PMID23642479C17	DM4JWMA	Discovery agent	N.A.	Investigative	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20523-8.
2	Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol. 2011 Jan 28;18(1):67-76.
3	Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing. J Med Chem. 2011 Jun 23;54(12):4172-86.
4	Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun15;23(12):3654-61.